Stingray Therapeutics
Houston, US · Founded 2018
Biotech
Founders & leadership
JP
Jonathan P. NorthrupExecutive Officer, Director, Promoter
SA
Scott Andrew JordanExecutive Officer, Director, Promoter
SP
Sunil P. SharmaExecutive Officer, Director, Promoter
Reported raises · per SEC filings
Form D private placements$25KraisedMay 2024 · 1 investors · Biotechnology
Rule 506(b)$436.8KraisedFeb 2024 · 21 investors · Biotechnology
Rule 506(b)$6.6MraisedDec 2023 · 52 investors · Biotechnology
Rule 506(b)$1.5MraisedMay 2021 · 9 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.